Reaction

Stenotrophomonas Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,322 reports · 99 co-occurring drugs

As of the last recalculation, Stenotrophomonas Infection appears in 1,322 FAERS reports alongside 99 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR SODIUM (PRR 66.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ganciclovir Sodium	43	66.1	66.4
Meropenem	121	65.2	65.5
Basiliximab	43	59.5	59.7
Busulfan	52	54.1	54.3
Micafungin Sodium	28	53.1	53.3
Thiotepa	30	50.6	50.7
Ganciclovir	30	47.2	47.3
Fludarabine Phosphate	106	46.1	46.2
Tacrolimus Ointment 0.1%	286	45.9	46.0
Tacrolimus Extended-Release Capsules	286	45.7	45.8
Voriconazole Injection	58	43.9	44.1
Posaconazole Delayed-Release	29	42.5	42.6
Cefepime Hydrochloride	42	42.4	42.5
Valganciclovir Hydrochloride Powder,	32	42.3	42.4
Amphotericin B	32	41.2	41.3
Cefepime	36	40.6	40.7
Tacrolimus	310	40.4	40.5
Azacitidine For	43	38.4	38.5
Mycophenolate Mofetil Hydrochloride	253	36.0	36.0
Mycophenolate Mofetil	248	35.2	35.2
Cytarabine	122	35.1	35.2
Vancomycin	117	34.9	34.9
Valganciclovir	40	34.4	34.5
Valganciclovir Hydrochloride	40	34.4	34.5
Voriconazole	62	33.7	33.7
Vancomycin Hydrochloride	126	33.2	33.2
Ampicillin	17	32.7	32.8
Ampicillin Sodium	17	32.7	32.8
Posaconazole	32	31.8	31.8
Remdesivir	25	30.1	30.1
Pegaspargase	23	30.1	30.1
Moxifloxacin	26	29.6	29.7
Azacitidine	52	28.7	28.7
Ceftriaxone	52	25.9	26.0
Ceftriaxone Sodium	57	24.4	24.4
Leucovorin Calcium	29	24.4	24.4
Methylprednisolone	184	24.2	24.2
Amikacin	25	23.5	23.5
Gentamicin Sulfate	23	23.3	23.3
Alemtuzumab	28	23.3	23.3
Piperacillin And Tazobactam	18	22.4	22.5
Sotalol Hydrochloride	23	22.1	22.2
Melphalan Hydrochloride	34	21.9	21.9
Moxifloxacin Hydrochloride	27	21.4	21.4
Azithromycin	52	21.1	21.2
Tobramycin	31	20.8	20.8
Melphalan	29	20.5	20.5
Azithromycin Monohydrate	52	20.4	20.4
Levofloxacin	73	20.1	20.1
Levofloxacin In 5% Dextrose	73	20.1	20.1
Fluticasone Furoate	15	19.7	19.7
Mercaptopurine	21	19.4	19.4
Fluconazole	80	19.1	19.1
Tobramycin Solution	14	18.5	18.6
Piperacillin Sodium,Tazobactam Sodium	30	18.2	18.2
Tobramycin Sulfate	14	18.0	18.0
Minocycline	13	17.7	17.7
Anti-Thymocyte Globulin (Rabbit)	9	17.7	17.7
Azithromycin Dihydrate	62	17.4	17.4
Etoposide	76	17.2	17.2
Daptomycin	10	17.2	17.2
Piperacillin Sodium And Tazobactam Sodium	21	17.1	17.1
Budesonide	60	16.7	16.8
Baricitinib	10	16.4	16.5
Mycophenilic Acid	21	16.2	16.2
Everolimus Tablets	17	16.2	16.2
Norepinephrine Bitartrate	14	15.5	15.5
Cyclosporine	101	15.4	15.4
Imatinib	17	15.4	15.4
Erythromycin	18	15.3	15.3
Cyclophosphamide Injection, Solution	150	14.9	14.9
Cyclophosphamide	150	14.9	14.9
Cyclophosphamide For Injection	150	14.9	14.9
Thiamine Hydrochloride	11	14.0	14.0
Dornase Alfa	17	13.8	13.8
Lumacaftor And Ivacaftor	7	12.9	12.9
Clarithromycin	27	12.6	12.6
Linezolid	23	12.4	12.4
Gentamicin	10	12.1	12.1
Oseltamivir	6	11.9	11.9
Ruxolitinib	52	11.9	11.9
Mesna Injection	6	11.5	11.5
Mesna	6	11.3	11.3
Ursosiol	13	10.6	10.6
Mycophenolic Acid	21	10.5	10.5
Vedolizumab	54	10.2	10.3
Pyrazinamide	6	10.1	10.1
Cladribine	6	9.9	9.9
Hydroxyurea	13	9.8	9.8
Acyclovir	61	8.8	8.8
Vincristine Sulfate	15	8.1	8.1
Venetoclax	31	8.1	8.1
Blinatumomab	5	7.6	7.6
Eltrombopag Olamine	11	7.6	7.6
Tofacitinib Citrate	6	7.2	7.2
Acalabrutinib	5	6.5	6.5
Axicabtagene Ciloleucel	4	6.4	6.4
Ivacaftor	3	6.0	6.0
Pegfilgrastim	17	2.7	2.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.